COL1A2 and hepatocellular carcinoma: Specifically, let-7g has been shown to reduce proliferation and migration of HCC cells by inhibiting Col1α2 expression, which indicates the therapeutic potential of the let-7/Col1α2 signaling axis in HCC [36].